Dulera

Dulera earns a findability score of 55 out of 100, placing it in the moderate-difficulty range. As a brand-name combination inhaler with no generic equivalent currently available, Dulera can be harder to track down than more widely stocked asthma medications. An active shortage of the 100 mcg/5 mcg strength reported since September 2025 has further complicated availability at many retail pharmacies.

The lack of a generic option means patients are limited to the brand product manufactured by Organon. Insurance formularies often place Dulera on higher tiers or require step therapy through preferred alternatives like generic Symbicort or Advair first, which can add delays. If your pharmacy is out of stock, Medfinder can help you locate nearby pharmacies that currently have Dulera in stock.

Dulera is commonly prescribed by several types of healthcare providers:

• Pulmonologists — lung specialists who manage moderate to severe asthma
• Allergists and immunologists — specialists in asthma triggered by allergies
• Primary care physicians and family medicine doctors — for ongoing asthma management
• Internists — for adult patients with asthma
• Pediatricians — for children ages 5 and older with asthma

Dulera is also available through telehealth consultations, which can be a convenient option for established asthma patients who need prescription renewals.

No, Dulera is not a controlled substance. It is not classified under any DEA schedule. You do not need special prescriptions or ID verification to fill it, though a valid prescription from a licensed healthcare provider is still required.

The most commonly reported side effects of Dulera include:

• Nasopharyngitis (inflammation of the nose and throat)
• Sinusitis
• Headache
• Upper respiratory tract infections
• Oral candidiasis (thrush) — rinsing your mouth after use helps prevent this
• Hoarseness (dysphonia)
• Increased heart rate

Important safety information: Dulera carries a boxed warning about the risk of asthma-related death associated with LABAs. It should only be used when asthma is not adequately controlled on an inhaled corticosteroid alone. Serious but less common side effects include adrenal insufficiency, paradoxical bronchospasm, reduced bone mineral density, glaucoma, cataracts, and growth suppression in children. Contact your doctor immediately if you experience worsening breathing, chest pain, or severe allergic reactions.

Dulera remains an effective option for managing moderate to persistent asthma, but finding it in 2026 can be a challenge. With no generic available, a cash price of $400 to $500, and an ongoing shortage of the 100 mcg/5 mcg strength, patients may need to do some legwork to fill their prescriptions.

If you have commercial insurance, the Organon Dulera Savings Card can reduce your copay to as little as $15 per prescription. Uninsured patients should explore the Organon Patient Assistance Program or consider switching to a more affordable generic alternative like Symbicort or Advair with their doctor's guidance.

Use Medfinder to search for pharmacies near you that currently have Dulera in stock — it can save you the frustration of calling around during a shortage.